SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Capricor Therapeutics, Inc. is a clinical-stage biotechnology company, which focuses on the development of transformative cell and exosome-based therapeutics for treating Duchenne muscular dystrophy (“DMD”), a rare form of muscular dystrophy which results in muscle degeneration and premature death, and other diseases with unmet medical needs. Its product candidate consists of CAP-1002, Engineered Exosomes, CAP-2003, and Exosome-Based Vaccine. The company was founded on June 17, 1996 and is headquartered in San Diego, CA.

Capricor Therapeutics Inc

Capricor Therapeutics is trending as investors react to the FDA lifting the hold on its Biologics License Application for Deramiocel and establishing a PDUFA date for August 2026. The community is focused on the potential for an earlier-than-expected approval, positive data readouts, and the company's long-term potential in the rare disease and exosome platform space.

Trump For President

The TRUMP ticker is experiencing intense volatility and social media backlash, driven by community skepticism regarding its association with the administration and frequent accusations of a "pump and dump" scheme. Investors are actively debating the token's long-term viability, with many critics highlighting its sharp price decline and drawing unfavorable comparisons to broader political controversies.

MARA Holdings, Inc. is a digital asset technology company, which engages in mining cryptocurrencies with a focus on the Bitcoin ecosystem. It also deals with owning and operating bitcoin mining facilities or data centers, selling proprietary software or technology to third parties operating in the Bitcoin ecosystem, offering advisory and consulting services to support Bitcoin mining ventures in domestic and international jurisdictions, and generating electricity from renewable energy resources or methane gas capture to power Bitcoin mining projects. The company was founded on February 23, 2010 and is headquartered in Hallandale Beach, FL.

MARA Holdings Inc.

Marathon Digital Holdings Inc

Marathon Digital is facing intense scrutiny as investors weigh its pivot into AI data centers against a persistent pattern of underperformance compared to broader crypto markets. The community remains deeply divided, with bulls pointing to undervalued assets and potential institutional accumulation, while skeptical traders and bears frequently criticize management's execution and the stock's tendency to amplify downside volatility.

Oracle Corp. engages in the provision of products and services that address aspects of corporate information technology environments, including applications and infrastructure technologies. It operates through the following business segments: Cloud and License, Hardware, and Services. The Cloud and License segment markets, sells, and delivers enterprise applications and infrastructure technologies through cloud and on-premise deployment models including cloud services and license support offerings. The Hardware segment provides infrastructure technologies including Oracle Engineered Systems, servers, storage, industry-specific hardware, operating systems, virtualization, management, and other hardware-related software. The Services segment offers consulting, advanced support, and education services. The company was founded by Lawrence Joseph Ellison, Robert Nimrod Miner, and Edward A. Oates on June 16, 1977 and is headquartered in Austin, TX.

Oracle Corp.

Oracle is seeing intense trading activity as investors react to a strong quarterly earnings report featuring a massive increase in remaining performance obligations and bullish AI infrastructure guidance. While community sentiment is divided between optimism over long-term cloud demand and skepticism regarding persistent short selling and market manipulation, many are closely monitoring key technical levels and analyst price target revisions.

Rubrik, Inc. engages in the provision of cloud data management solutions. Its solutions include backup and recovery, VM backup, Microsoft 365, ransom ware recovery, database backup, cloud solutions, and Polaris sonar. Rubrik products include data protection, data threat analytics, data security posture and cyber recovery. The company was founded by Bipul Sinha, Arvind Jain, Soham Mazumdar, and Arvind Nithrakashyap in December 2013 and is headquartered in Palo Alto, CA.

Rubrik Inc. - Ordinary Shares - Class A

Rubrik Inc. - Class A

Rubrik is facing significant downward volatility as market participants express frustration over price action and perceived manipulation, despite the company's strong revenue growth and expanding footprint in AI-driven data security. Investors are actively debating whether current valuation concerns and sector-wide weakness are temporary setbacks or fundamental risks, leading to heated discussions about the sustainability of their business model versus broader enterprise adoption.

Meta Platforms, Inc. engages in the development of social media applications. It builds technology that helps people connect and share, find communities, and grow businesses. It operates through the Family of Apps (FoA) and Reality Labs (RL) segments. The FoA segment consists of Facebook, Instagram, Messenger, WhatsApp, and other services. The RL segment includes augmented, mixed and virtual reality related consumer hardware, software, and content. The company was founded by Mark Elliot Zuckerberg, Dustin Moskovitz, Chris R. Hughes, Andrew McCollum, and Eduardo P. Saverin on February 4, 2004, and is headquartered in Menlo Park, CA.

Meta Platforms Inc - Ordinary Shares - Class A

Meta Platforms Inc

Meta is facing intense market volatility as investors weigh the delayed rollout of its "Avocado" AI model against news of a potential shift in its massive data center infrastructure strategy. While some traders are expressing frustration over the recent downward price action and persistent spending concerns, others view the current dip as a strategic buying opportunity, pointing to the company's aggressive in-house chip development and long-term ad revenue growth as key pillars for future stability.

Lennar Corp. engages in the provision of real estate related financial and investment management services. It operates through the following segments: Homebuilding, Financial Services, Multifamily, and Lennar Other. The Homebuilding segment refers to the construction and sale of single-family attached and detached homes and the purchase, development, and sale of residential land directly and through entities. The Financial Services segment focuses on mortgage financing, title, and closing services for buyers. The Multifamily segment is involved in the development, construction, and property management of multifamily rental properties. The Lennar Other segment includes funds, asset management platform, and strategic investments in technology companies. The company was founded in 1954 and is headquartered in Miami, FL.

Lennar Corp. - Ordinary Shares - Class A

Lennar Corp.

Lennar is in the spotlight as investors weigh the company's recent earnings results and future guidance against the broader backdrop of persistent housing affordability challenges and shifting interest rate expectations. The community remains deeply divided, with some traders eyeing a potential short squeeze on fundamentally strong housing plays, while others express concerns that elevated home prices and high input costs could lead to further downside.

Ulta Beauty, Inc. engages in the retail of beauty products. The company has one reportable segment, which includes retail stores, salon services, and e-commerce. Its products include makeup, skin care, tools and brushes, fragrance, and bath and body. The company was founded on January 9, 1990 and is headquartered in Bolingbrook, IL.

Ulta Beauty Inc

Ulta Beauty is experiencing significant volatility following a mixed earnings report where a top-line beat and guidance hike were offset by concerns over the company's long-term growth trajectory and margin pressures. Community sentiment is deeply divided, with some traders viewing the post-earnings pullback as a prime buying opportunity for a resilient consumer brand, while others highlight the stock's elevated valuation and recent technical weakness as reasons to remain bearish.

Immuneering Corp. operates as a clinical-stage oncology company, which engages in developing medicines for cancer patients. Its pipeline of drug candidates focuses on treating aspects of disease that have eluded conventional approaches, including cancer cachexia and metastasis. The company was founded by Robert J. Carpenter and Benjamin J. Zeskind in 2008 and is headquartered in Cambridge, MA.

Immuneering Corp - Ordinary Shares Class A

Immuneering Corp

Immuneering Corp is seeing significant volatility as investors weigh promising early-stage clinical data for its pancreatic cancer treatment against broader sector pressure and concerns about potential share offerings. The community remains deeply divided, with many long-term shareholders highlighting insider buying and upcoming pivotal trial milestones as catalysts for a potential reversal, while others are wary of short-selling activity and the stock's recent price decline.

Soleno Therapeutics, Inc. operates as clinical-stage biopharmaceutical company, which engages in the development and commercialization of novel therapeutics for the treatment of rare diseases. It focuses on the treatment of metabolic and neurobehavioral disorder. It offers its lead candidate, Diazoxide Choline Controlled-Release (DCCR), an oral tablet for the treatment of Prader-Willi Syndrome (PWS). The company was founded on August 25, 1999 and is headquartered in Redwood City, CA.

Soleno Therapeutics Inc

Soleno Therapeutics is facing significant volatility following reports of patient deaths identified through the FDA's FAERS database, which has fueled a short attack by Scorpion Capital despite company assurances that the events were not related to their Prader-Willi syndrome drug, VYKAT XR. While some investors are concerned about the regulatory and reputational fallout, the community remains divided, with many long-term holders treating the price dip as a buying opportunity and pointing to the drug's approved status and market position as reasons for resilience.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

🐉 $PLCE CALL — DragonAlgo® Signal

Contract: PLCE CALL
Expiry: 2026-03-20 | Strike: $6.00 | Type: CALL

Option Plan (premium):
Entry: $0.05
Stop: $0.04
TP1: $0.07
TP2: $0.09
TP3: $0.12

🔗 https://dragonalgo.com

Dragonalgo

DragonAlgo

StockTwits Web

Childrens Place Inc

 CALL — DragonAlgo® Signal

Contract: PLCE CALL
Expiry: 2026-03-20 | Strike: $6.00 | Type: CALL

Option Plan (premium):
Entry: $0.05
Stop: $0.04
TP1: $0.07
TP2: $0.09
TP3: $0.12

🔗 